Advertisements
Pietrantonio, Filippo

Pietrantonio, Filippo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2025 Rank: 51,931

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 1,563 out of 355,674 Researchers

Data For The Year: 2025
Metrics Self-Citations Excluded All
Rank Based on Composite Score51,93150,387
Total Cites1,9142,150
H-index2123
Hm-index45
Number of Single Authored Papers44
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers5353
Total Cites to Single+First Authored Papers285309
Number of Single+First+Last Authored Papers121121
Total Cites to Single+First+Last Authored Papers778850
Composite Score22
Number of Distinct Citing Papers1,4391,546
Ratio of Total Citations to Distinct Citing Papers 1.33 1.39
Self-Citation Percentage
10.98%
Found an error in your data? Contact us with your profile link. Contact Us →
Pietrantonio, Filippo

Pietrantonio, Filippo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2024 Rank: 36,760

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 1,170 out of 334,837 Researchers

Data For The Year: 2024
Metrics Self-Citations Excluded All
Rank Based on Composite Score36,76034,349
Total Cites1,5491,804
H-index1922
Hm-index45
Number of Single Authored Papers44
Total Cites to Single Authored Papers33
Number of Single+First Authored Papers5252
Total Cites to Single+First Authored Papers304341
Number of Single+First+Last Authored Papers110110
Total Cites to Single+First+Last Authored Papers580671
Composite Score33
Number of Distinct Citing Papers1,1761,281
Ratio of Total Citations to Distinct Citing Papers 1.32 1.41
Self-Citation Percentage
14.14%
Found an error in your data? Contact us with your profile link. Contact Us →
Pietrantonio, Filippo

Pietrantonio, Filippo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2023 Rank: 87,478

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 3,145 out of 312,644 Researchers

Data For The Year: 2023
Metrics Self-Citations Excluded All
Rank Based on Composite Score87,47878,836
Total Cites1,2371,466
H-index1617
Hm-index44
Number of Single Authored Papers44
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers5050
Total Cites to Single+First Authored Papers262310
Number of Single+First+Last Authored Papers9898
Total Cites to Single+First+Last Authored Papers440532
Composite Score22
Number of Distinct Citing Papers9931,083
Ratio of Total Citations to Distinct Citing Papers 1.25 1.35
Self-Citation Percentage
15.62%
Found an error in your data? Contact us with your profile link. Contact Us →
Pietrantonio, Filippo

Pietrantonio, Filippo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2022 Rank: 60,941

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 2,316 out of 293,195 Researchers

Data For The Year: 2022
Metrics Self-Citations Excluded All
Rank Based on Composite Score60,94150,223
Total Cites1,0731,304
H-index1517
Hm-index34
Number of Single Authored Papers44
Total Cites to Single Authored Papers22
Number of Single+First Authored Papers5050
Total Cites to Single+First Authored Papers317365
Number of Single+First+Last Authored Papers9191
Total Cites to Single+First+Last Authored Papers421510
Composite Score23
Number of Distinct Citing Papers889991
Ratio of Total Citations to Distinct Citing Papers 1.21 1.32
Self-Citation Percentage
17.71%
Found an error in your data? Contact us with your profile link. Contact Us →
Pietrantonio, Filippo

Pietrantonio, Filippo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2021 Rank: 59,441

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 2,152 out of 271,773 Researchers

Data For The Year: 2021
Metrics Self-Citations Excluded All
Rank Based on Composite Score59,44157,046
Total Cites1,3761,652
H-index1820
Hm-index45
Number of Single Authored Papers44
Total Cites to Single Authored Papers44
Number of Single+First Authored Papers4747
Total Cites to Single+First Authored Papers428503
Number of Single+First+Last Authored Papers7777
Total Cites to Single+First+Last Authored Papers565682
Composite Score33
Number of Distinct Citing Papers1,1201,241
Ratio of Total Citations to Distinct Citing Papers 1.23 1.33
Self-Citation Percentage
16.71%
Found an error in your data? Contact us with your profile link. Contact Us →
Pietrantonio, Filippo

Pietrantonio, Filippo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2020 Rank: 131,592

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 4,569 out of 230,678 Researchers

Data For The Year: 2020
Metrics Self-Citations Excluded All
Rank Based on Composite Score131,592113,260
Total Cites732911
H-index1316
Hm-index33
Number of Single Authored Papers33
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers4343
Total Cites to Single+First Authored Papers262330
Number of Single+First+Last Authored Papers7575
Total Cites to Single+First+Last Authored Papers339430
Composite Score22
Number of Distinct Citing Papers600668
Ratio of Total Citations to Distinct Citing Papers 1.22 1.36
Self-Citation Percentage
19.65%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements